**Core Concept**
Bare Lymphocyte Syndrome (BLS) is a rare primary immunodeficiency disorder characterized by impaired antigen presentation, leading to a failure in T-cell activation and proliferation. This condition is primarily caused by mutations in genes encoding components of the major histocompatibility complex (MHC) class II, which are essential for presenting antigens to T-cells.

**Why the Correct Answer is Right**
The correct answer is related to the defective expression of MHC class II molecules. MHC class II molecules are expressed on the surface of antigen-presenting cells (APCs), such as dendritic cells and B-cells, and are responsible for presenting peptide fragments of proteins to CD4+ T-cells. In BLS, mutations in genes encoding MHC class II subunits (e.g., HLA-DP, HLA-DQ, or HLA-DR) lead to impaired expression of these molecules on the surface of APCs, resulting in a failure to activate T-cells. This defect is a critical component of the pathophysiology of BLS, leading to a severe impairment of immune function.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because defects in MHC class I expression are associated with a different group of immunodeficiency disorders, such as the HLA class I deficiency syndrome, which affects the presentation of antigens to CD8+ T-cells.

**Option B:** This option is incorrect because TAP1 and TAP2 are components of the transporter associated with antigen processing (TAP), which is responsible for transporting peptide fragments into the endoplasmic reticulum for loading onto MHC class I molecules, not MHC class II.

**Option C:** This option is incorrect because CD4 is a co-receptor on T-cells that interacts with MHC class II molecules, but it is not directly involved in the expression or function of MHC class II molecules.

**Clinical Pearl / High-Yield Fact**
It is essential to recognize that Bare Lymphocyte Syndrome is a rare but important immunodeficiency disorder that highlights the critical role of MHC class II molecules in antigen presentation and T-cell activation. Understanding the pathophysiology of BLS can help clinicians diagnose and manage patients with this condition, as well as other immunodeficiency disorders that affect antigen presentation.

**Correct Answer:**
(Answer is missing, please provide the correct answer)